Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Moreau

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Hemasphere|July 21, 2025
Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network databaseThomas Grange, Elsa Poullot, Marie Parrens, et al.
Kidney International|October 28, 2022
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipientsAurélie Moreau, Delphine Kervella, Laurence Bouchet-Delbos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Lepretre, Aurore Touzart, Thomas Vermeulin, et al.
ACS Chemical Biology|November 10, 2011
Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinasePeter Axerio-Cilies, Raymond H See, Roya Zoraghi, et al.
The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Haematologica|August 4, 2022
Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohortMagali Colombat, Margot Gaspard, Mylène Camus, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug targetRoya Zoraghi, Raymond H See, Peter Axerio-Cilies, et al.
Xenotransplantation|July 22, 2014
hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty modelBertrand Vabres, Stéphanie Le Bas-Bernardet, David Riochet, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
The New England Journal of Medicine|September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell LymphomaSteven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Hemasphere|July 21, 2025
Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network databaseThomas Grange, Elsa Poullot, Marie Parrens, et al.
Kidney International|October 28, 2022
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipientsAurélie Moreau, Delphine Kervella, Laurence Bouchet-Delbos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Lepretre, Aurore Touzart, Thomas Vermeulin, et al.
ACS Chemical Biology|November 10, 2011
Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinasePeter Axerio-Cilies, Raymond H See, Roya Zoraghi, et al.
The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Haematologica|August 4, 2022
Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohortMagali Colombat, Margot Gaspard, Mylène Camus, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug targetRoya Zoraghi, Raymond H See, Peter Axerio-Cilies, et al.
Xenotransplantation|July 22, 2014
hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty modelBertrand Vabres, Stéphanie Le Bas-Bernardet, David Riochet, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
The New England Journal of Medicine|September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell LymphomaSteven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Pageof 16